Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L30 pseudogene 5 (RPL30P5) is a processed pseudogene related to the ribosomal protein L30 gene family[2][8][10]. Unlike its parent gene, which encodes a component of the large 60S ribosomal subunit involved in protein synthesis[4][7], RPL30P5 does not produce a functional protein and is not transcribed into active ribosomal protein—it is an inactive DNA sequence, the result of a past duplication and retrotransposition event[1][2][11]. As a processed pseudogene, RPL30P5 lacks biological function and is not considered a therapeutic target. There are no known disease roles, drug interactions, or biomarker relevance for this pseudogene. Its presence is a common genomic feature of ribosomal protein gene families, which often have many such pseudogenes distributed throughout the genome[2][10][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L30 pseudogene 5 (RPL30P5).